-
Bausch Health Companies Inc. (formerly
Valeant Pharmaceuticals International, Inc.) is an American-Canadian
multinational specialty pharmaceutical company...
-
pharmaceutical company executive. He is the
former chairman and CEO of
Valeant Pharmaceuticals International after being ousted in the
aftermath of a...
-
system posed by
Valeant's business model and
controversial pricing practices.
Ackman opened his
testimony saying, "As a
shareholder of
Valeant, I recognize...
-
approval in 1989 for
commercial reasons.
Valeant Pharmaceuticals acquired the
rights from
Lilly in 2004.
Valeant tried and
failed to get the medication...
- were
released by
Valeant Pharmaceuticals and
hedge fund CEO, Bill Ackman,
about a $46
billion (CAD)
offer presented to Allergan.
Valeant proposed to exchange...
-
cosmetics company based in Bridgewater, New Jersey. It is a
subsidiary of
Valeant Pharmaceuticals,
which acquired the
company in 2012.
Medicis is
known for...
- in the
United States.
Until 2020,
Valeant was the sole
marketer of
Seconal in the
United States. As of 2021,
Valeant discontinued the product, and Bausch...
- on
Valeant Pharmaceuticals, the Fund
indicated it was
reopening to new investors. In 2016, the fund lost $1.26
billion in a
single day when
Valeant Pharmaceuticals...
- the
legality of
operations by Nu Skin Enterprises, and a 2015
report on
Valeant Pharmaceuticals bringing attention to
inflated sales. In
October 2015,...
-
operations of
Valeant became public,
Ackman and
Valeant's board fired former CEO Mike Pearson, and
Pershing Square sold all of its
stake in
Valeant with a total...
